Linked Life Data

11382265

Source:http://linkedlifedata.com/resource/pubmed/id/11382265

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-5-30
pubmed:abstractText
Neuropsychological changes develop in patients treated by cytokine immunotherapy with interleukin-2 (IL-2) and interferon-alpha (IFN-alpha). However, the time course of appearance of these effects remains unclear, and their precise nature is still incompletely characterized. The objective of this study was to assess and characterize the early cognitive changes induced by IL-2 and IFN-alpha in cancer patients at the end of the first week of treatment and to investigate the subsequent evolution of these changes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0033-3174
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
376-86
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.
pubmed:affiliation
INSERM U394, Neurobiologie Intégrative, Institut François Magendie, Bordeaux, France. lcapuro@emory.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't